v3.25.4

Segment Information (Tables)

9 Months Ended

Dec. 28, 2025

Segment Reporting [Abstract]

Summary of Segment Information

Summarized financial information for our reportable segments is presented and reconciled to consolidated financial information in the following tables:

(In thousands)			Water Treatment						Food & Health Sciences						Industrial Solutions						Total
Three months ended December 28, 2025:
Sales			$	120,487					$	70,004					$	53,589					$	244,080
Cost of sales - materials			(73,957)						(50,710)						(42,529)						(167,196)
Cost of sales - operational overhead			(16,976)						(5,447)						(3,648)						(26,071)
Gross profit			29,554						13,847						7,412						50,813
Selling, general, and administrative expenses			(16,715)						(8,166)						(3,376)						(28,257)
Operating income			12,839						5,681						4,036						22,556
Interest expense, net																					(3,434)
Other income																					459
Income tax expense																					(5,269)
Net income																					14,312
Identifiable assets*			564,689						244,038						132,946						941,673
Capital expenditures			8,021						2,941						3,359						14,321
Depreciation and amortization			7,902						3,290						2,218						13,410

(In thousands)			Water Treatment						Food & Health Sciences						Industrial Solutions						Total
Three months ended December 29, 2024:
Sales			$	99,752					$	77,730					$	48,723					$	226,205
Cost of sales - materials			(58,546)						(55,944)						(38,075)						(152,565)
Cost of sales - operational overhead			(15,350)						(5,497)						(4,369)						(25,216)
Gross profit			25,856						16,289						6,279						48,424
Selling, general, and administrative expenses			(16,058)						(7,761)						(3,542)						(27,361)
Operating income			9,798						8,528						2,737						21,063
Interest expense, net																					(1,216)
Other income																					436
Income tax expense																					(5,262)
Net income																					15,021
Identifiable assets*			124,713						306,859						242,334						673,906
Capital expenditures			4,361						2,113						2,248						8,722
Depreciation and amortization			4,808						3,151						2,152						10,111
Nine months ended December 28, 2025:
Sales			$	420,961					$	232,095					$	164,730					$	817,786
Cost of sales - materials			(251,930)						(169,677)						(130,508)						(552,115)
Cost of sales - operational overhead			(52,469)						(13,742)						(8,642)						(74,853)
Gross profit			116,562						48,676						25,580						190,818
Selling, general, and administrative expenses			(57,871)						(24,631)						(10,487)						(92,989)
Operating income			58,691						24,045						15,093						97,829
Interest expense, net																					(10,535)
Other income																					2,122
Income tax expense																					(23,331)
Net income																					66,085
Capital expenditures			22,614						7,728						8,321						38,663
Depreciation and amortization			22,660						9,704						6,599						38,963
Nine months ended December 29, 2024:
Sales			$	341,456					$	234,225					$	153,432					$	729,113
Cost of sales - materials			(195,807)						(168,545)						(120,321)						(484,673)
Cost of sales - operational overhead			(48,657)						(13,423)						(9,059)						(71,139)
Gross profit			96,992						52,257						24,052						173,301
Selling, general, and administrative expenses			(45,962)						(22,582)						(10,158)						(78,702)
Operating income			51,030						29,675						13,894						94,599
Interest expense, net																					(3,906)
Other income																					1,268
Income tax expense																					(23,943)
Net income																					68,018
Capital expenditures			15,910						6,695						7,403						30,008
Depreciation and amortization			13,673						9,362						6,333						29,368

*Unallocated assets not included, consisting primarily of cash and cash equivalents, prepaid expenses, and non-qualified deferred compensation plan assets of $34.9 million at December 28, 2025 and $33.3 million at December 29, 2024.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration